ReviewJournal of human immunity2025
Human genetic influences on early B cell development.
Review in Journal of human immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Human Peripheral B Cell Subsets: Evolving notions about B cell biology and the broad relevance of B cells in disease.Immunological reviews · 2026Review
- First 2-year experience of nationwide newborn screening for severe forms of T and B cell immunodeficiency: 2.3 million newborns analyzed using TREC and KREC in Russia.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Early B cells develop centrally and then migrate peripherally to mediate the essential immune functions of antigen presentation, immune regulation, and immunoglobulin production. B cell development is tightly regulated, ensuring the generation of distinctive B cell clones, each carrying a fixed B cell receptor and therefore antigen specificity. Defects in B cell development can underlie a variety of clinical phenotypes, including immunodeficiency, autoimmunity, and B cell leukemia. The study of human genetic variation has enabled the discovery of critical pathways for immune cell development, differentiation, and generation of immune repertoire diversity. Here, we focus on the complete allelic spectrum impacting central B cell development, including rare and common genetic variation, to shed light on unique and shared mechanisms underlying predisposition to B cell lymphopenia, autoimmunity, and leukemia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.